MedTrace Logo

Efficacy and Safety of NeuroEndoscopic Surgery for Large IntraCerebral Hemorrhage

NCT06894433 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 280

Last updated 2025-05-18

No results posted yet for this study

Summary

This is a multicenter, randomized, controlled clinical trial comparing neuroendoscopic hematoma removal to craniotomy in the treatment of large intracerebral hemorrhage.

Conditions

  • Intracerebral Haemorrhage

Interventions

PROCEDURE

neuroendoscopic surgery

Subjects will receive Neuroendoscopic Surgery followed by standard medical management

PROCEDURE

craniotomy

Subjects will receive Craniotomy followed by standard medical management

Sponsors & Collaborators

  • Southwest Hospital, China

    lead OTHER

Principal Investigators

  • Rong Hu, MD · PLA Army Medical University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-06-01
Primary Completion
2028-06-30
Completion
2028-12-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06894433 on ClinicalTrials.gov